Unlocking Longevity with GLP-1: A Key to Turn Back the Clock?

GLP-1 and the Science of Aging

Glucagon-like peptide-1 (GLP-1) receptor agonists, primarily known for their roles in managing diabetes and obesity, are now being explored for their potential to extend healthy lifespan and combat age-related diseases. With their diverse biological effects, GLP-1 therapies are emerging as powerful tools not just for metabolic health but also for promoting longevity and overall wellness.

If you’re curious about the potential of GLP-1 therapies to optimise your health and longevity, book a consultation with our specialist team.

Click here to book a Microdosing Nurse Discussion Appointment

How GLP-1 Promotes Longevity

1. Combatting Oxidative Stress and Cellular Senescence:
   – GLP-1 activates the Nrf2 signalling pathway, which protects cells from oxidative damage and reduces the effects of ageing (Oh et al., 2017).
   – It prevents endothelial cell senescence by activating protein kinase A, improving vascular health and delaying age-related decline (Oeseburg et al., 2010).
2. Improving Metabolic Health:
   – GLP-1 therapies enhance insulin sensitivity and glucose metabolism, which are critical for preventing age-related metabolic disorders such as diabetes and obesity (Müller et al., 2019).
   – By regulating appetite and promoting weight loss, GLP-1 reduces risk factors associated with cardiovascular disease and other chronic illnesses (Drucker, 2021).
3. Neuroprotection and Cognitive Health:
   – GLP-1 receptor agonists exhibit neuroprotective properties, reducing amyloid-beta accumulation and supporting neuronal survival in conditions like Alzheimer’s and Parkinson’s diseases (Reich et al., 2022; Perry et al., 2004).
4. Stimulating Autophagy and Cellular Renewal:
   – GLP-1 therapies promote autophagy, a process that removes damaged cellular components, thus enhancing tissue rejuvenation and reducing the risk of age-related diseases (Sharma et al., 2011).
5. Enhancing Cardiovascular Health:
   – GLP-1 receptor agonists improve endothelial function, reduce arterial stiffness, and decrease inflammation, contributing to cardiovascular longevity (Wilbon et al., 2023).

Click here to book a Microdosing Nurse Discussion Appointment

Evidence Supporting GLP-1 for Longevity

1. Metabolic Health and Lifespan Extension:
   Kreiner et al. (2023) highlighted the ability of GLP-1 receptor agonists to address ageing-related diseases, such as diabetes, obesity, and kidney disease, potentially extending healthy lifespan.
2. Oxidative Stress Reduction:
   Oh et al. (2017) demonstrated how GLP-1 protects against oxidative damage by activating Nrf2, a key regulator of cellular defence mechanisms.
3. Neuroprotection in Ageing:
   Reich et al. (2022) reviewed the neuroprotective effects of GLP-1 mimetics, showing promise in treating Alzheimer’s and Parkinson’s diseases.
4. Autophagy and Anti-Ageing Mechanisms:
   Sharma et al. (2011) found that GLP-1 analogues enhance autophagy, a critical process for cellular repair and longevity.

Why Microdosing GLP-1 Could Optimise Longevity

Microdosing GLP-1 receptor agonists involves starting with smaller doses and gradually increasing them to therapeutic levels. This approach offers several benefits:

• Improved Tolerability: Reduces side effects such as nausea and gastrointestinal discomfort.
• Gradual Adaptation: Allows the body to acclimate to the medication, ensuring long-term compliance.
• Early Intervention: Provides an opportunity for individuals to begin preventive therapies for age-related conditions.

If you’re considering microdosing GLP-1 therapies for longevity, our specialists can help you design a personalised plan to suit your needs.

Click here to book a Microdosing Nurse Discussion Appointment